Stevens RG - Search Results

1

Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study.

Zhu Y, Stevens RG, Hoffman AE, Fitzgerald LM, Kwon EM, Ostrander EA, Davis S, Zheng T, Stanford JL. Zhu Y, et al. Among authors: stevens rg. Cancer Res. 2009 Dec 15;69(24):9315-22. doi: 10.1158/0008-5472.CAN-09-0648. Cancer Res. 2009. PMID: 19934327 Free PMC article.

2

CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses.

Hoffman AE, Yi CH, Zheng T, Stevens RG, Leaderer D, Zhang Y, Holford TR, Hansen J, Paulson J, Zhu Y. Hoffman AE, et al. Among authors: stevens rg. Cancer Res. 2010 Feb 15;70(4):1459-68. doi: 10.1158/0008-5472.CAN-09-3798. Epub 2010 Feb 2. Cancer Res. 2010. PMID: 20124474 Free PMC article.

3

The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling.

Hoffman AE, Zheng T, Yi CH, Stevens RG, Ba Y, Zhang Y, Leaderer D, Holford T, Hansen J, Zhu Y. Hoffman AE, et al. Among authors: stevens rg. Cancer Prev Res (Phila). 2010 Apr;3(4):539-48. doi: 10.1158/1940-6207.CAPR-09-0127. Epub 2010 Mar 16. Cancer Prev Res (Phila). 2010. PMID: 20233903 Free PMC article.

4

Phenotypic effects of the circadian gene Cryptochrome 2 on cancer-related pathways.

Hoffman AE, Zheng T, Ba Y, Stevens RG, Yi CH, Leaderer D, Zhu Y. Hoffman AE, et al. Among authors: stevens rg. BMC Cancer. 2010 Mar 24;10:110. doi: 10.1186/1471-2407-10-110. BMC Cancer. 2010. PMID: 20334671 Free PMC article.

5

Genetic and epigenetic associations of circadian gene TIMELESS and breast cancer risk.

Fu A, Leaderer D, Zheng T, Hoffman AE, Stevens RG, Zhu Y. Fu A, et al. Among authors: stevens rg. Mol Carcinog. 2012 Dec;51(12):923-9. doi: 10.1002/mc.20862. Epub 2011 Oct 17. Mol Carcinog. 2012. PMID: 22006848

6

Period3 structural variation: a circadian biomarker associated with breast cancer in young women.

Zhu Y, Brown HN, Zhang Y, Stevens RG, Zheng T. Zhu Y, et al. Among authors: stevens rg. Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):268-70. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15668506

7

Does "clock" matter in prostate cancer?

Zhu Y, Zheng T, Stevens RG, Zhang Y, Boyle P. Zhu Y, et al. Among authors: stevens rg. Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):3-5. doi: 10.1158/1055-9965.EPI-05-0631. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16434577 Free PMC article.

8

Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.

Zhu Y, Leaderer D, Guss C, Brown HN, Zhang Y, Boyle P, Stevens RG, Hoffman A, Qin Q, Han X, Zheng T. Zhu Y, et al. Among authors: stevens rg. Int J Cancer. 2007 Jan 15;120(2):432-5. doi: 10.1002/ijc.22321. Int J Cancer. 2007. PMID: 17096334 Free PMC article.

9

Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.

Zhu Y, Stevens RG, Leaderer D, Hoffman A, Holford T, Zhang Y, Brown HN, Zheng T. Zhu Y, et al. Among authors: stevens rg. Breast Cancer Res Treat. 2008 Feb;107(3):421-5. doi: 10.1007/s10549-007-9565-0. Epub 2007 Apr 24. Breast Cancer Res Treat. 2008. PMID: 17453337 Free PMC article.

10

Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2.

Hoffman AE, Zheng T, Stevens RG, Ba Y, Zhang Y, Leaderer D, Yi C, Holford TR, Zhu Y. Hoffman AE, et al. Among authors: stevens rg. Cancer Res. 2009 Apr 15;69(8):3605-13. doi: 10.1158/0008-5472.CAN-08-4572. Epub 2009 Mar 24. Cancer Res. 2009. PMID: 19318546 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters